Creutzfeldt-Jakob disease in Germany: A prospective 12-year surveillance

Brain

Volumn 130, Issue 5, 2007, Pages 1350-1359

  Heinemann, U ^a   Krasnianski, A ^a   Meissner, B ^a   Varges, D ^a   Kallenberg, K ^a   Schulz Schaeffer, W J ^a   Steinhoff, B J ^b   Grasbon Frodl, E M ^c   Kretzschmar, H A ^c   Zerr, I ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Epilepsiezentrum Kork   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

CJD; Codon 129 genotype; CSF; Dementia; Diagnosis; Epidemiology; Genetic CJD; MRI; Reversible treatable dementia

Indexed keywords

GROWTH HORMONE; PRION PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CADAVER; CODON; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGICAL DATA; EUROPE; FEMALE; GENE MUTATION; GENOTYPE; GERMANY; HUMAN; IATROGENIC DISEASE; INCIDENCE; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; AGE DISTRIBUTION; GENETIC POLYMORPHISM; GENETICS; HEALTH SURVEY; METHODOLOGY; MIDDLE AGED;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; GENOTYPE; GERMANY; HUMANS; INCIDENCE; MIDDLE AGED; POLYMORPHISM, GENETIC; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; PRPSC PROTEINS;

EID: 34249680730     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm063     Document Type: Article

References (67)

1. Bersano A, Fiorini M, Allaria S, Zanusso G, Fasoli E, Gelati M, et al. Detection of CSF 14-3-3 protein in Guillain-Barre syndrome. Neurology 2006; 67: 2211-6.
2. Boesenberg C, Schulz-Schaeffer WJ, Meissner B, Kallenberg K, Bartl M, Heinemann U, et al. Clinical course in young patients with sporadic Creutzfeldt-Jakob disease. Ann Neurol 2005; 58: 533-43.
3. Brandel JP, Delasnerie-Laupretre N, Laplanche JL, Hauw JJ, Alperovitch A. Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology 2000; 54: 1095-9.
4. Brown P, Brandel JP, Preese M, Sato T. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006; 67: 389-93.
5. Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55: 1075-81.
6. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389: 498-501.
7. Castellani RJ, Colucci M, Xie Z, Zou W, Li C, Parchi P, et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004; 63: 436-42.
8. Collins S, Boyd A, Lee JS, Lewis V, Fletcher A, McLean CA, et al. Creutzfeldt-Jakob disease in Ausralia 1970-1999. Neurology 2002; 59: 1365-71.
9. Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, et al. Determinants of diagnostic investigation results across the clinical spectrum of sporadic CJD. Brain 2006; 129: 2278-87.
10. de Pedro-Cuesta J, Glatzel M, Almazan J, Stoeck K, Mellina V, Puopolo M, et al. Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002. BMC Public Health 2006; 10: 278.
11. Deslys JP, Jaegly A, d'Aignaux JH, Mouthon F, de Villemeur TB, Dormont D. Genotype at codon 129 and susceptibility to Creutzfeldt-Jakob disease [letter]. Lancet 1998; 351: 1251.
12. Glatzel M, Ott PM, Linder T, Gebbers JO, Gmur A, Wust W, et al. Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol 2003; 2: 757-63.
13. Glatzel M, Rogivue C, Ghani A, Streffer JR, Amsler L, Aguzzi A. Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet 2002; 360: 139-41.
14. Grasbon-Frodl E, Schmalzbauer R, Weber P, Krebs B, Windl O, Zerr I, et al. A novel three extra-repeat insertion in the prion protein gene (PRNP) in a patient with Creutzfeldt-Jakob disease. Neurogenetics 2004a; 5: 249-50.
15. Grasbon-Frodl EM, Lorenz H, Mann U, Nitsch RM, Windl O, Kretzschmar HA. Loss of glycosylation associated with the T183A mutation in human prion disease. Acta Neuropathol 2004b; 108: 476-84.
16. Haik S, Brandel JP, Sazdovitch V, Delasnerie-Lauprêtre N, Peoc'h K, Laplanche J-L, et al. Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology 2000; 55: 1401-4.
17. Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 2003; 74: 1206-9.
18. Hoffman Snyder C, Mishark KJ, Caviness JN, Drazkowski JF, Caselli RJ. Nonvasculitic autoimmune inflammatory meningoencephalitis imitating Creutzfeldt-Jakob disease. Arch Neurol 2006; 63: 766-8.
19. Johnson RT. Prion diseases. Lancet Neurol 2005; 4: 635-42.
20. Kallenberg K, Schulz-Schaeffer W, Jastrow U, Poser S, Meissner B, Tschampa H, et al. Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences. Am J Neuroradiol 2006; 27: 1459-62.
21. Kitamoto T, Shin RW, Doh-Ura K, Tomokane N, Miyazono M, Muramoto T, et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 1992; 140: 1285-94.
22. Kovacs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, Van Duijn C, et al. Genetic prion disease: the EUROCJD experience. Hum Genet 2005; 118: 166-74.
23. Krasemann S, Zerr I, Weber T, Poser S, Kretzschmar HA, Hunsmann G, et al. Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. Brain Res Mol Brain Res 1995; 34: 173-6.
24. Krasnianski A, Meissner B, Schulz-Schaeffer W, Kallenberg K, Bartl M, Heinemann U, et al. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2006a; 63: 876-80.
25. Krasnianski A, Schulz-Schaeffer WJ, Kallenberg K, Meissner B, Collie DA, Roeber S, et al. Clinical findings and diagnostic tests in the MV-2 subtype of sporadic CJD. Brain 2006b; 129: 2288-96.
26. Krebs B, Lederer R-M, Windl O, Grasbon-Frodl E-M, Zerr I, Kretzschmar HA. Creutzfeldt-Jakob disease associated with an R148H mutation of the prion protein gene. Neurogenetics 2005; 6: 97-100.
27. Kretzschmar H, Sethi S, Földvári Z, Windl O, Querner V, Zerr I, et al. Iatrogenic Creutzfeldt-Jakob disease with florid plaques. Brain Pathol 2003; 13: 245-9.
28. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 913-20.
29. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005; 64: 1586-91.
30. Lang CJ, Heckmann JG, Neundorfer B. Creutzfeldt-Jakob disease via dural and corneal transplants. J Neurol Sci 1998; 160: 128-39.
31. Lang CJ, Heckmann JG, Querner V, Neundorfer B, Kornhuber J, Buchfelder M, et al. Disease latency in Creutzfeldt-Jakob disease via dural grafting: a case report. Eur J Epidemiol 2001; 17: 1013-4.
32. Lang CJ, Schuler P, Engelhardt A, Spring A, Brown P. Probable Creutzfeldt-Jakob disease after a cadaveric dural graft. Eur J Epidemiol 1995; 11: 79-81.
33. Lee HS, Sambuughin N, Cervenakova L, Chapman J, Pocchiari M, Litvak S, et al. Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease. Am J Hum Genet 1999; 64: 1063-70.
34. Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, et al. Possible transmission of variant Creutzfeld-Jakob disease by blood transfusion. Lancet 2004; 363: 417-21.
35. McMurtray A, Clark DG, Christine D, Mendez MF. Early-onset dementia: frequency and causes compared to late-onset dementia. Dement Geriatr Cogn Disord 2006; 21: 59-64.
36. Meissner B, Westner I, Kallenberg K, Krasnianski A, Bartl M, Varges D, et al. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 2005; 65: 1544-50.
37. Nakamura Y, Yanagawa H, Hoshi K, Yoshino H, Urata J, Sato T. Incidence rate of Creutzfeldt-Jakob disease in Japan. Int J Epidemiol 1999; 28: 130-4.
38. Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 1998; 147: 574-80.
39. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-33.
40. Peden A, Head MW, Ritchie D, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527-9.
41. Pocchiari M, Poupolo M, Croes EA, Budka H, Gelpi E, Collins S, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004; 10: 2348-59.
42. Poser S, Mollenhauer B, Krauss A, Zerr I, Steinhoff BJ, Schröter A, et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999; 122: 2345-51.
43. Puopolo M, Ladogana A, Almonti S, Daude N, Bevivino S, Petraroli R, et al. Mortality trend from sporadic Creutzfeldt-Jakob disease (CJD) in Italy, 1993-2000. J Clin Epidemiol 2003; 56: 494-9.
44. Roeber S, Krebs B, Neumann M, Windl O, Zerr I, Grasbon-Frodl EM, et al. Creutzfeldt-Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment. Acta Neuropathol 2005; 109: 443-8.
45. Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging 2001; 22: 575-80.
46. Saiz A, Nos C, Yague J, Dominguez A, Graus F, Munoz P. The impact of the introduction of the 14-3-3 protein assay in the surveillance of sporadic Creutzfeldt-Jakob disease in Catalonia. Catalan Collaborative Study Group for CJD. J Neurol 2001; 248: 592-4.
47. Sampson EL, Warren JD, Rossor MN. Young onset dementia. Postgrad Med J 2004; 80: 125-39.
48. Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sanchez-Valle R, Mitrova E, et al. Cerebrospinal fluid tests in the differential diagnosis of CJD. Neurology 2006; 67: 637-43.
49. Sanchez-Valle R, Nos C, Yague J, Graus F, Dominguez A, Saiz A. Clinical and genetic features of human prion diseases in Catalonia: 1993-2002. Eur J Neurol 2004; 11: 649-55.
50. Schulz-Schaeffer WJ, Fatzer R, Vandevelde M, Kretzschmar HA. Detection of PrP(Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot. Arch of Virol 2000; 16: 173-80.
51. Slee M, Pretorius P, Ansorge O, Stacey R, Butterworth R. Parkinsonism and dementia due to gliomatosis cerebri mimicking sporadic Creutzfeldt-Jakob disease (CJD). JNNP 2006; 77: 283-4.
52. Steinhoff BJ, Räcker S, Herrendorf G, Poser S, Grosche S, Zerr I, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 162-6.
53. Swerdlow AJ, Higgins CD, Adlard P, Jones ME, Preece MA. Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology 2003; 61: 783-91.
54. Tschampa HJ, Neumann M, Zerr I, Henkel K, Schröter A, Schulz-Schaeffer WJ, et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 71: 33-9.
55. Valadi N, Morgan JC, Sethi KD. Psychogenic movement disorder masquerading as CJD. J Neuropsych Clin Neurosci 2006; 18: 562-3.
56. Van Everbroeck B, Michotte A, Sciot R, Godfraind C, Deprez M, Quoilin S, et al. Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium. Eur J Epidemiol 2006; 21: 443-7.
57. Vander T, Hallevy C, Alsaed I, Valdman S, Ifergane G, Wirguin I. 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy. J Neurol 2004; 251: 1273-4.
58. WHO. Human transmissible spongiform encephalopathies. Wkly Epidemiol Rec 1998; 47: 361-5.
59. Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull 2003; 66: 255-65.
60. Will RG, Alpérovitch A, Poser S, Pocchiari M, Hofman A, Mitrova E, et al. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD. Ann Neurol 1998; 43: 763-7.
61. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-5.
62. Will RG, Zeidler M, Stewart GE, Macleod MA, Ironside JW, Cousens SN, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000; 47: 575-82.
63. Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, et al. Molecular genetics of human prion diseases in Germany. Hum Genet 1999; 105: 244-52.
64. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006; 368: 2061-7.
65. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43: 32-40.
66. Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RSG, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000a; 55: 811-5.
67. Zerr I, Schulz-Schaeffer WJ, Giese A, Bodemer M, Schröter A, Henkel K, et al. Current clinical diagnosis in CJD: identification of uncommon variants. Ann Neurol 2000b; 48: 323-9.